Elanco Animal Health (5EA) Stock Statistics & Valuation Metrics

Elanco Animal Health has a market cap or net worth of EUR 10.28B. The enterprise value is EUR 15.84B.

Market Cap

EUR 10.28B

Enterprise Value

EUR 15.84B

Elanco Animal Health has 499,621,830 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

499,621,830

Owned by Insiders

1.01%

Owned by Institutions

2.33%

Elanco Animal Health’s return on equity (ROE) is -0.04 and return on invested capital (ROIC) is 2.13%.

Return on Equity (ROE)

-0.04

Return on Assets (ROA)

-0.02

Return on Invested Capital (ROIC)

2.13%

Return on Capital Employed (ROCE)

0.02

Revenue Per Employee

488.60K

Profits Per Employee

-24.04K

Employee Count

9,650

Asset Turnover

0.35

Inventory Turnover

1.53

The current PE Ratio of Elanco Animal Health is -56.24. Elanco Animal Health’s PEG ratio is 0.36.

PE Ratio

-56.24

PS Ratio

2.29

PB Ratio

1.75

Price to FCF

30.39

Price to Operating Cash Flow

18.67

PEG Ratio

0.36

In the last 12 months, Elanco Animal Health had revenue of 4.71B and earned -232.00M in profits. Earnings per share was -0.47.

Revenue

4.71B

Gross Profit

2.05B

Operating Income

252.00M

Pretax Income

-224.00M

Net Income

-232.00M

EBITDA

676.00M

Earnings Per Share (EPS)

-0.47

In the last 12 months, operating cash flow was 617.00M and capital expenditures -238.00M, giving a free cash flow of 379.00M billion.

Operating Cash Flow

617.00M

Free Cash Flow

379.00M

Free Cash Flow per Share

0.76

Elanco Animal Health pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share

―

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

3.29%

Earnings Yield

-1.73%

Beta

0.79

52-Week Price Change

3.50%

50-Day Moving Average

20.07

200-Day Moving Average

20.38

Relative Strength Index (RSI)

49.55

Average Volume (3m)

436

Elanco Animal Health upcoming earnings date is Nov 06, 2026, Before Open (Not Confirmed).

Last Earnings Date

Aug 05, 2026

Next Earnings Date

Nov 06, 2026

Ex-Dividend Date

―

Elanco Animal Health as a current ratio of 2.17, with Debt / Equity ratio of 61.36%

Current Ratio

2.17

Quick Ratio

1.08

Debt to Market Cap

0.36

Net Debt to EBITDA

5.14

Interest Coverage Ratio

1.15

In the past 12 months, Elanco Animal Health has paid 8.00M in taxes.

Income Tax

8.00M

Effective Tax Rate

-0.04

Elanco Animal Health EV to EBITDA ratio is 19.26, with an EV/FCF ratio of 39.33.

EV to Sales

2.97

EV to EBITDA

19.26

EV to Free Cash Flow

39.33

EV to Operating Cash Flow

24.16

Elanco Animal Health has EUR 530.00M in cash and marketable securities with EUR 3.92B in debt, giving a net cash position of -EUR 3.39B billion.

Cash & Marketable Securities

EUR 530.00M

Total Debt

EUR 3.92B

Net Cash

-EUR 3.39B

Net Cash Per Share

-EUR 6.78

Tangible Book Value Per Share

-EUR 2.92

Gross margin is 52.59%, with operating margin of 9.20%, and net profit margin of -3.96%.

Gross Margin

52.59%

Operating Margin

9.20%

Pretax Margin

-3.31%

Net Profit Margin

-3.96%

EBITDA Margin

15.42%

EBIT Margin

1.61%

The average price target for Elanco Animal Health is EUR 27.59, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target

EUR 27.59

Price Target Upside

35.91% Upside

Analyst Consensus

Strong Buy

Analyst Count

14

Revenue Growth Forecast

4.41%

EPS Growth Forecast

-142.94%

Smart Score

7

AI Score

―